Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.





Magnifying Glass

Areas of Interest for RNA Therapeutics


Technology Platform – Drug Delivery

siRNA Delivery Vehicles for Systemic Administration

  • Novel polymers and lipids for encapsulation
  • Low toxicity and biodegradable
  • Amenable to use of process development & manufacturing platforms
  • Amenable to molecular targeting strategies
  • Long-term storage stability
  • Delivery Vehicles that improve endosomal escape

Oligonucleotide Optimization

siRNA Sequence, Structure, and Modification

  • Novel chemistries for improving resistance to enzymatic degradation
  • Novel chemistries for reducing immunostimulation
  • Enhanced RISC incorporation
  • Long-term chemical stability
  • Improved target specificity

Approaches to Molecular Targeting of siRNA

  • Targeting using antibodies, peptides, or small molecules
  • Specific for disease-relevant cell types
  • Suitable for nanoparticle or liposome delivery

Assays for siRNA Intracellular Functions

  • Assays for siRNA endosomal escape
  • Biochemical assays for strand selection, RISC incorporation,
    catalytic efficiency
  • Assays for clinical biodistribution
  • Cell-based assays to measure Toll receptor activation

Validated siRNA Targets

  • Demonstrated reduction in mRNA and protein levels in animals
  • Reductions have expected effect on disease phenotype

miRNA

  • Novel chemistries to create antagomirs
  • Demonstrated reduction of miRNA levels in animals, with evidence that reductions have expected effects on mRNA levels and/or disease phenotype
  • Demonstrated delivery of miRNA in animals, with evidence that increases in miRNA have expected effects on mRNA levels and/or disease phenotype

RNA Manufacturing

  • Advancements in large-scale production of modified siRNA
  • Improved processes for increased quality, efficiency, and reduced COG
  • Novel chemistries
  • Universal linker based solid support for production of siRNAs
  • Robust LC-MS method for determination of impurity profile of phosphoramidite raw materials and oligonucleotides (siRNAs)

Information Technology

  • Registration and tracking of information related to complex multi-component biologics

 


SITE MAP PRIVACY POLICYTERMS OF USECOPYRIGHT © 1995-2005 MERCK & CO., INC.